ArticleCancer research2010

Essential requirement for PP2A inhibition by the oncogenic receptor c-KIT suggests PP2A reactivation as a strategy to treat c-KIT+ cancers.

Kathryn G Roberts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.